Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for anesthesia induction and maintenance in elderly joint replacement surgery
ChiCTR2500102723Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in nonelective condition (2 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoints: Mean arterial pressure, Heart rate and 2 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
nonelective condition
Beyond the preview
Go deeper on ChiCTR2500102723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102723.